US 11780837
CXCR4 inhibitors and uses thereof
granted A61PA61P35/00
Quick answer
US patent 11780837 (CXCR4 inhibitors and uses thereof) held by X4 Pharmaceuticals, Inc. expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- X4 Pharmaceuticals, Inc.
- Grant date
- Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P35/00